August 10, 2016
The acquisition makes Mayne Pharma one of the 25 largest retail generic pharmaceutical companies in the United States and the second-largest generic oral contraceptive provider, the company said. 
August 5, 2016

Teva’s generic will be available in 100- and 400-mg dosage strengths.

August 4, 2016
The products have combined U.S. sales of $3.5 billion for the 12 months ended June 2016, according to IMS Health. 
August 4, 2016

USA Today is reporting that CVS Health has announced plans to remove two biologic drugs, Neupogen and Lantus, from its pharmacy benefits manager (PBM) formulary in 2017 and replace them with biosimilars of the drugs, substituting Zarxio for Neupogen and Basaglar for Lantus. Biosimilars cost about 15% to 30% less than the original biologics. CVS’s EVP and chief medical officer Troyen Brennan told USA Today that the biologics were reviewed by panels of experts “to make sure they are considered equivalent. (USA Today)

August 3, 2016

With generic drugs saving the healthcare system millions of dollars, Drug Store News caught up with Jim Cannon, Greenstone VP and general manager, to discuss authorized generics.

August 3, 2016

Drug Store News caught up with TopRx president Scott Franklin to discuss what’s on the horizon for the national distributor of generic pharmaceuticals.

August 3, 2016

Anda is the fourth-largest generics distributor in the U.S., and it distributes generic, branded and OTC pharmaceuticals from more than 300 manufacturers.

August 2, 2016

Total spending on products whose patents expired between 2012 and 2015 declined by $14.2 billion last year, according to IMS Health’s Institute for Health Care informatics. And 2016 could bring about further cost reductions.

August 2, 2016

As some companies prepare to market their biosimilars, others are still in development. At the end of 2015, the IMS Institute noted that there were five biosimilars in the pre-registration phase of development.

August 2, 2016

Due to an agreement with Ferring Pharmaceuticals, which markets Lysteda, Amerigen may launch its generic under license at an undisclosed future date. 

August 2, 2016
Mylan’s generic will be available in 5-, 10- and 15-mg dosage strengths.
August 2, 2016

Among the biosimilars researchers focused on was Inflectra, which was developed by Pfizer’s Hospira as a biosimilar to Janssen Biotech’s Remicade. 

August 1, 2016
Aurobindo has chosen the 90-acre East Windsor campus as its U.S. headquarters, and when the manufacturing and distribution center is fully operational, it is expected to generate 400-500 new jobs. 
July 28, 2016

With the final regulatory hurdle behind it, the company said it expects the $40.5 billion transaction to complete next week.

July 26, 2016

Teva Pharmaceutical and Mylan have shown preliminary interest in a Brazilian generic drug-making joint-venture in which Pfizer has a 40% stake, according to Fortune. (Fortune)

July 25, 2016

Boothe had previously served as Perrigo’s EVP and general manager, where he was responsible for U.S. pharmaceuticals, including generics and specialty.

July 25, 2016

For the 12 months ended May 31, the product had U.S. sales of $6.7 billion. 

July 25, 2016

Pennsylvania Wolf’s signing of Senate Bill 514 has earned him praise from both the Biotechnology Innovation Organization (BIO) and Pennsylvania Bio.

July 22, 2016

Apotex  has launched rosuvastatin calcium tablets, the generic equivalent of Crestor by AstraZeneca.

July 22, 2016

Teva Pharmaceuticals has added Sumatriptan Injection, USP (autoinjector) to its line of generic products. 

July 20, 2016

The finding points to a potential gap in competition that has allowed prices for some generics to climb.

July 20, 2016

The pilot program would allow the Department of Defense to access lower pricing for prescriptions dispensed at community pharmacies.

July 20, 2016

"Working together with NCPA staff, the Innovation Center will help better position independent community pharmacies to be part of and benefit from broader health care changes," suggested Doug Hoey, NCPA CEO.

July 19, 2016
Ajanta’s Axert generics will be available in 6.25- and 12.5-mg dosage strength.